LIXTE appoints Sidney Braun CEO of Liora; GBP 50K signing bonus, GBP 25K monthly retainer

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Braun becomes CEO of Liora Technologies Europe Ltd., effective Feb 13, 2026.
Signing bonus of GBP 50,000 plus monthly retainer of GBP 25,000 (both excl. VAT).
If Liora is sold, Braun gets 20% of net purchase price via Allocation Deed.
Braun helped create Liora and facilitated LIXTE's acquisition of Liora's assets in Nov 2025.
He brings 20+ years healthcare experience; previously built Remicade infusion network.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.